CHAllenges in Managing and Preventing Pain (CHAMPP) Clinical Research Center, University of Pittsburgh, Pittsburgh, PA, USA.
Division of General Internal Medicine, Center for Research on Health Care, University of Pittsburgh, Pittsburgh, PA, USA.
Subst Abus. 2023 Jul;44(3):226-234. doi: 10.1177/08897077231186677. Epub 2023 Sep 14.
Therapeutic use of cannabis is common in the United States (up to 18.7% of Americans aged ≥12), and dispensaries in the US are proliferating rapidly. However, the efficacy profile of medical cannabis is unclear, and customers often rely on dispensary staff for purchasing decisions. The objective was to describe cannabis dispensary staff perceptions of medical cannabis benefits and risks, as well as its safety in high-risk populations.
Online Survey study conducted using Qualtrics from February 13, 2020 to October 2, 2020 with a national sample of dispensary staff who reportedinteracting with customers in a cannabis dispensary selling tetrahydrocannabinol-containing products. Participants were queried about benefits ("helpfulness") and risks ("worry") about cannabis for a variety of medical conditions, and safety in older adults and pregnant women on a five-point Likert scale. These results were then collapsed into three categories including "neutral" (3/5). "I don't know" (uncertainty) was a response option for helpfulness and safety.
Participants (n = 434) were from 29 states and included patient-facing dispensary staff (40%); managers (32%); pharmacists (13%); and physicians, nurse practitioners, or physician assistants (5%). Over 80% of participants perceived cannabis as helpful for post-traumatic stress disorder (88.7%), epilepsy (85.3%) and cancer (83.4%). Generally, participants were not concerned about potential cannabis risks, including increased use of illicit drugs (76.3%), decreases in intelligence (74.4%), disrupted sleep (71.7%), and new/worsening health problems from medical cannabis use (70.7%). Cannabis was considered safe in older adults by 81.3% of participants, though there was much less consensus on safety in pregnancy.
Cannabis dispensary staff generally view medical cannabis as beneficial and low-risk. However, improvements in dispensary staff training, an increased role for certifying clinicians, and interventions to reduce dispensary staff concerns (e.g., cost, judgment) may improve evidence-based staff recommendations to patients seeking medical cannabis.
在美国,大麻的治疗用途很常见(12 岁及以上的美国人中高达 18.7%),美国的大麻药房也在迅速增多。然而,医用大麻的疗效情况并不清楚,顾客在购买时往往依赖药房工作人员的建议。本研究旨在描述大麻药房工作人员对医用大麻益处和风险的看法,以及其在高危人群中的安全性。
这是一项于 2020 年 2 月 13 日至 10 月 2 日期间通过 Qualtrics 进行的在线调查研究,调查对象为全国范围内在销售含四氢大麻酚产品的大麻药房中与顾客互动的药房工作人员。参与者被问及大麻在各种医疗状况下的益处(“有用性”)和风险(“担忧”),以及在老年人和孕妇中的安全性,他们对这些问题的看法按五分制量表进行评价。这些结果随后被分为三类,包括“中性”(3/5)。“我不知道”(不确定)是有用性和安全性的回答选项。
共有 434 名参与者,来自 29 个州,包括面向患者的药房工作人员(40%)、管理人员(32%)、药剂师(13%)和医生、护士从业者或医师助理(5%)。超过 80%的参与者认为大麻对创伤后应激障碍(88.7%)、癫痫(85.3%)和癌症(83.4%)有帮助。一般来说,参与者并不担心潜在的大麻风险,包括非法药物使用增加(76.3%)、智力下降(74.4%)、睡眠障碍(71.7%)和使用医用大麻导致新的/恶化的健康问题(70.7%)。81.3%的参与者认为大麻对老年人是安全的,尽管对于孕妇使用大麻的安全性共识较少。
大麻药房工作人员普遍认为医用大麻有益且风险低。然而,改善药房工作人员培训、增加认证临床医生的作用,以及减少药房工作人员对成本、判断等问题的担忧(例如,成本、判断),可能会改善为寻求医用大麻的患者提供的基于证据的工作人员建议。